题名

Wilhelm Brünings' forgotten contribution to the metabolic treatment of cancer utilizing hypoglycemia and a very low carbohydrate (ketogenic) diet

DOI

10.1016/j.jtcme.2018.06.002

作者

Rainer Johannes Klement

关键词

Cancer ； Hypoglycemia ； Insulin ； Ketogenic diet ； Low carbohydrate diet

期刊名称

Journal of Traditional and Complementary Medicine

卷期/出版年月

9卷3期（2019 / 07 / 01）

页次

192 - 200

内容语文

英文
中文摘要

The growing interest in the alterations of tumor cell metabolism and their possible therapeutic exploitation also spurred new complementary and integrative approaches such as treating patients with a ketogenic diet (KD). KDs aim at inhibiting glycolytic tumor metabolism and growth, and have therefore been proposed as adjuncts not only to standard-of-care, but also to other therapies targeting tumor metabolism. Here I describe the life and forgotten work of one of the earliest researchers who realized the importance of altered tumor cell metabolism and its possible exploitation through metabolic modifications: Wilhelm Brünings. Brünings was a German natural scientist and physician famous for his innovative contributions to the fields of physiology and otorhinolaryngology. Based on the findings of Otto Warburg and his physiological reasoning he started to experiment with insulin administration and KDs in his patients with head and neck cancers, aiming to maximally lower blood glucose concentrations. He obtained encouraging short-term results, although most tumors became refractory to treatment after several weeks. His pioneering work is worth revisiting, especially for an international readership that may be unaware of his efforts, as hypoglycemic treatments, including the use of insulin injections and KDs, are currently being re-investigated as complementary and integrative cancer treatments.
主题分类 醫藥衛生 > 中醫藥學
参考文献
  1. Abdelwahab, MG,Fenton, KE,Preul, MC(2012).The ketogenic diet is an effective adjuvant to radiation therapy for the treatment of malignant glioma.PLoS One,7(5),e36197.
  2. Adrian, TE,Bloom, SR(1985).The continuing hormonal contamination of insulin.Pract Diabetes Int,2(6),34-36.
  3. Ahmad, IM,Aykin-Burns, N,Sim, JE(2005).Mitochondrial O2- and H2O2 mediate glucose deprivation-induced stress in human cancer cells.J Biol Chem,280(6),4254-4263.
  4. Akanmu, MA,Nwabudike, NL,Ilesanmi, OR(2009).Analgesic, learning and memory and anxiolytic effects of insulin in mice.Behav Brain Res,196(2),237-241.
  5. Allen, BG,Bhatia, SK,Anderson, CM(2014).Ketogenic diets as an adjuvant cancer therapy: history and potential mechanism.Redox Biol,2,963-970.
  6. Allen, BG,Bhatia, SK,Buatti, JM(2013).Ketogenic diets enhance oxidative stress and radio-chemo-therapy responses in lung cancer xenografts.Clin Canc Res,19(14),3905-3913.
  7. Artzi, M,Liberman, G,Vaisman, N(2017).Changes in cerebral metabolism during ketogenic diet in patients with primary brain tumors: 1H-MRS study.J Neurooncology,132(2),267-275.
  8. Aykin-Burns, N,Ahmad, IM,Zhu, Y,Oberley, LW,Spitz, DR(2009).Increased levels of superoxide and H2O2 mediate the differential susceptibility of cancer cells versus normal cells to glucose deprivation.Biochem J,418,29-37.
  9. Bartmann, C,Raman, SRJ,Flöter, J(2018).Beta-hydroxybutyrate (3-OHB) can influence the energetic phenotype of breast cancer cells, but does not impact their proliferation and the response to chemotherapy or radiation.Canc Metabol,6,8.
  10. Bishop, JS,Marks, PA(1959).Studies on carbohydrate metabolism in patients with neoplastic disease. II. Response to insulin administration.J Clin Invest,38(4),668-667.
  11. Branca, JJV,Pacini, S,Ruggiero, M(2015).Effects of pre-surgical vitamin D supple-mentation and ketogenic diet in a patient with recurrent breast cancer.Anticancer Res,35(10),5525-5532.
  12. Breitkreutz, R,Tesdal, K,Jentschura, D,Haas, O,Leweling, H,Holm, E(2005).Effects of a high-fat diet on body composition in cancer patients receiving chemotherapy: a randomized controlled study.Wien Klin Wochenschr,117(19-20),685-692.
  13. Brünings W. Beiträge zum Krebsproblem. 1. Mitteilung: Ueber eine diätetisch-hormonale Beeinflussung des Krebses. Münchener Med Wochenschr. 1941;88(5):117-123.
  14. Brünings W. Beitrage zum Krebsproblem. 2. Mitteilung: Klinische Anwen-dungen der diätetisch-hormonalen Krebsbeeinflussung (“Entzuck-erungsmethode”). Münchener Med Wochenschr. 1942;89(4):71-76.
  15. Brünings W. Beitrage zur Elektrophysiologie. I. Mitteilung. Vorbemerkungen -Ueber den Ruhestrom des Froschmuskels I. Pflügers Arch - Eur J Physiol. 1903;98(5e6):241e283. https://link.springer.com/article/10.1007/BF01663447
  16. Brünings W. Beitrage zur Elektrophysiologie. II. Mitteilung. Ueber Ruhestrom und Reizung. Pflügers Arch - Eur J Physiol. 1903;100(7-8):367-427. https://link.springer.com/article/10.1007/BF01663094
  17. Brünings W. Beiträge zur Elektrophysiologie. III. Mitteilung. Zur osmotischen Theorie der Zellelektrizität. Pflügers Arch - Eur J Physiol. 1907;117(7-9): 409-460
  18. Brünings W. Beitrage zur Physiologie des Tetanus. Erste Mitteilung. Ueber die Muskeltone bei elektrischer Tetanisierung des ausgeschnittenen Froschgas-trocnemius. Pflügers Arch - Eur J Physiol. 1903;93(7-8):302-326. https://link.springer.com/article/10.1007/BF01663253
  19. Brünings W. Beträge zum Krebsproblem - Schluß. Münchener Med Wochenschr. 1942;89(4):102-107.
  20. Brünings W. Ein neuer Apparat für Blutkörperchenzählung. Pflügers Arch - Eur J Physiol. 1903;93(9-10):377-411
  21. Champ, CE,Palmer, JD,Volek, JS(2014).Targeting metabolism with a ketogenic diet during the treatment of glioblastoma multiforme.J Neurooncol,117(1),125-131.
  22. Chang, HT,Olson, LK,Schwartz, KA(2013).Ketolytic and glycolytic enzymatic expression profiles in malignant gliomas: implication for ketogenic diet therapy.Nutr Metab,10,47.
  23. Chu-Shore, CJ,Thiele, EA(2010).Tumor growth in patients with tuberous sclerosis complex on the ketogenic diet.Brain Dev.,32(4),318-322.
  24. Cicero, AFG,Fogacci, F,Colletti, A(2017).Potential role of bioactive peptides in prevention and treatment of chronic diseases: a narrative review.Br J Pharmacol,174(11),1378-1394.
  25. Condon, HA(1987).Brünings' bronchoscopic mask.Anaesthesia,42,996-997.
  26. Demetrakopoulos, GE,Linn, B,Amos, H(1978).Rapid loss of ATP by tumor cells deprived of glucose: contrast to normal cells.Biochem Biophys Res Commun,82(3),787-794.
  27. Drenick, EJ,Alvarez, LC,Tamasi, GC,Brickman, AS(1972).Resistance to symptomatic insulin reactions after fasting.J Clin Invest,51(10),2757-2762.
  28. Elsakka, AMA,Bary, MA,Abdelzaher, E(2018).Management of glioblastoma multiforme in a patient treated with ketogenic metabolic therapy and modified standard of care: a 24-month follow-up.Front Nutr,5,20.
  29. Fearon, KC,Borland, W,Preston, T,Tisdale, MJ,Shenkin, A,Calman, KC(1988).Cancer cachexia: influence of systemic ketosis on substrate levels and nitrogen metabolism.Am J Clin Nutr,47(1),42-48.
  30. Fine, EJ,Miller, A,Quadros, EV,Sequeira, JM,Feinman, RD(2009).Acetoacetate reduces growth and ATP concentration in cancer cell lines which over-express uncoupling protein 2.Canc Cell Int,9,14.
  31. Fine, EJ,Segal-isaacson, CJ,Feinman, RD(2012).Targeting insulin inhibition as a metabolic therapy in advanced cancer: a pilot safety and feasibility dietary trial in 10 patients.Nutrition,28(10),1028-1035.
  32. Freedland, SJ,Allen, J,Armstrong, AJ(2018).Interim analysis of a prospective randomized trial of dietary carbohydrate restriction for men with a rising PSA after failed primary treatment: Carbohydrate and Prostate Study 2 (CAPS2).J Clin Oncol,36(Suppl. 6S),382.
  33. Gaude, E,Frezza, C(2014).Defects in mitochondrial metabolism and cancer.Canc Metabol,2,10.
  34. Graham, NA,Tahmasian, M,Kohli, B,Komisopoulou, E,Zhu, M,Vivanco, I(2012).Glucose deprivation activates a metabolic and signaling amplification loop leading to cell death.Mol Syst Biol,8,589.
  35. Greifenstein A. Wilhelm Brünings zum 60. Geburtstage. Arch f Ohren - Nasen-u Kehlkopfheilkd. 1936;141:1-4. https://doi.org/10.1007/BF01583586
  36. Hamaguchi, R,Wada, H(2018).Paradigm shift in cancer treatment: cancer treatment as a metabolic disease fusion of Eastern and Western medicine.J Tradit Chinese Med Sci
  37. Hao, G-W,Chen, Y-S,He, D-M,Wang, H-Y,Wu, G-H,Zhang, B(2015).Growth of human colon cancer cells in nude mice is delayed by ketogenic diet with or without omega-3 fatty acids and medium-chain triglycerides.Asian Pac J Cancer Prev,16(5),2061-2068.
  38. Holm, E,Kammerer, U(2011).Lipids and carbohydrates in nutritional concepts for tumor patients.Aktuel Ernahrungsmed,36,286-298.
  39. Hyde, PN,Lustberg, MB,Miller, VJ,LaFountain, RA,Volek, JS(2017).Pleiotropic effects of nutritional ketosis: conceptual framework for keto-adaptation as a breast cancer therapy.Cancer Treat Res Commun,12,32-39.
  40. İyikesici, MS,Slocum, AK,Slocum, A,Berkarda, FB,Kalamian, M,Seyfried, TN(2017).Efficacy of metabolically supported chemotherapy combined with ketogenic diet, hyperthermia, and hyperbaric oxygen therapy for stage IV triple-negative breast cancer.Cureus,9(7),e1445.
  41. Jansen, N,Walach, H(2016).The development of tumours under a ketogenic diet in association with the novel tumour marker TKTL1: a case series in general practice.Oncol Lett,11(11),584-592.
  42. Jelluma, N,Yang, X,Stokoe, D,Evan, GI,Dansen, TB,Haas-Kogan, DA(2006).Glucose withdrawal induces oxidative stress followed by apoptosis in glioblastoma cells but not in normal human astrocytes.Mol Canc Res,4(5),319-330.
  43. Kapelner, A,Vorsanger, M(2015).Starvation of cancer via induced ketogenesis and severe hypoglycemia.Med Hypotheses,84(3),162-168.
  44. Klement, RJ(2017).Beneficial effects of ketogenic diets for cancer patients: a realist review with focus on evidence and confirmation.Med Oncol,34,132.
  45. Klement, RJ(2017).Fasting, fats, and physics: combining ketogenic and radiation therapy against cancer.Complement Med Res
  46. Klement, RJ(2017).The influence of ketogenic therapy on the 5 R's of radiobiology.Int J Radiat Biol
  47. Klement, RJ,Fink, MK(2016).Dietary and pharmacological modification of the insulin/IGF-1 system: exploiting the full repertoire against cancer.Oncogenesis,5,e193.
  48. Klement, RJ,Kammerer, U(2011).Is there a role for carbohydrate restriction in the treatment and prevention of cancer?.Nutr Metab,8,75.
  49. Klement, RJ,Sweeney, RA(2016).Impact of a ketogenic diet intervention during radiotherapy on body composition: I. Initial clinical experience with six prospectively studied patients.BMC Res Notes,9,143.
  50. Koroljow, S.(1962).Two cases of malignant tumors with metastases apparently treated successfully with hypoglycemic coma.Psychiatr Q,36(1-4),261-270.
  51. Kressner, A(1956).Professor Dr. Brünings-80 Jahre alt.Bayer Ärzteblatt,11(3),57-58.
  52. Lundholm, K,Hoim, G,Schersten, T(1978).Insulin resistance in patients with cancer.Canc Res,38(12),4665-4670.
  53. Marchut, E,Guminska, M,Kedryna, T(1985).The inhibitory effect of various fatty acids on aerobic glycolysis in Ehrlich ascites tumour cells.Acta Biochim Pol,33(1),7-16.
  54. Martinez-Outschoorn, UE,Peiris-Pages, M,Pestell, RG,Sotgia, F,Lisanti, MP(2017).Cancer metabolism: a therapeutic perspective.Nat Rev Clin Oncol,14(2),113-113.
  55. Martin-McGill, KJ,Marson, AG,Smith, CT,Jenkinson, MD(2018).The modified keto-genic diet in adults with glioblastoma: an evaluation of feasibility and deliverability within the National Health Service the modi fi ed ketogenic diet in adults with glioblastoma: an evaluation.Nutr Canc
  56. Martin-McGill, KJ,Marson, AG,Tudur Smith, C,Jenkinson, MD(2017).Ketogenic diets as an adjuvant therapy in glioblastoma (the KEATING trial): study protocol for a randomised pilot study.Pilot Feasibility Stud,3,67.
  57. Martuscello, RT,Vedam-Mai, V,McCarthy, DJ(2016).A supplemented high-fat low-carbohydrate diet for the treatment of glioblastoma.Clin Canc Res,22(10),2482-2495.
  58. Masino, SA,Ruskin, DN(2013).Ketogenic diets and pain.J Child Neurol,28(8),993-1001.
  59. Mathews, EH,Liebenberg, L(2013).Cancer control via glucose and glutamine deprivation.J Intern Med,274(5),492.
  60. Maurer, GD,Brucker, DP,Bahr, O(2011).Differential utilization of ketone bodies by neurons and glioma cell lines: a rationale for ketogenic diet as experimental glioma therapy.BMC Canc,11,315.
  61. Miller, VJ,Villamena, FA,Volek, JS(2018).Nutritional ketosis and mitohormesis: potential implications for mitochondrial function and human health.J Nutr Metab,2018,5157645.
  62. Moreschi C. Beziehungen zwischen Ernahrung und Tumorwachstum. Z Immunitatsforsch. 1909;2(6):651-675
  63. Morscher, RJ,Aminzadeh-Gohari, S,Feichtinger, RG(2015).Inhibition of neuro-blastoma tumor growth by ketogenic diet and/or calorie restriction in a CD1-nu mouse model.PLoS One,10(6),e0129802.
  64. Morscher, RJ,Aminzadeh-Gohari, S,Hauser-Kronberger, C,Feichtinger, RG,Sperl, W,Kofler, B(2016).Combination of metronomic cyclophosphamide and dietary intervention inhibits neuroblastoma growth in a CD1-nu mouse model.Oncotarget,7(13),17060-17073.
  65. Nebeling, L,Miraldi, F,Shurin, S,Lerner, E(1995).Effects of a ketogenic diet on tumor metabolism and nutritional status in pediatric oncology patients: two case reports.J Am Coll Nutr,14(2),202-208.
  66. Nebeling, LC,Lerner, E(1995).Implementing a ketogenic diet based on medium-chain triglyceride oil in pediatric patients with cancer.J Am Diet Assoc,95(6),693-697.
  67. Oleksyszyn, J(2011).The complete control of glucose level utilizing the composition of ketogenic diet with the gluconeogenesis inhibitor, the anti-diabetic drug metformin, as a potential anti-cancer therapy.Med Hypotheses,77(2),171-173.
  68. Otto, C,Kaemmerer, U,Illert, B(2008).Growth of human gastric cancer cells in nude mice is delayed by a ketogenic diet supplemented with omega-3 fatty acids and medium-chain triglycerides.BMC Canc,8(1),122.
  69. Otto, C,Klingelhoffer, C,Biggermann, L(2014).Analysis of the metabolism of ketone bodies and lactate by gastrointestinal tumor cells in vitro.Aktuelle Ernahrungsmed,39,51-59.
  70. Payne WW, Lawrence RD, Mccance RA. Sorbitol (SIONON) for diabetics. Lancet. 1933;222(5753):1257-1258
  71. Permert, J,Adrian, TE,Jacobsson, P,Jorfelt, L,Fruin, AB,Larsson, J(1993).Is profound peripheral insulin resistance in patients with pancreatic cancer caused by a tumor-associated factor?.Am J Surg,165(1),61-66.
  72. Poff, A,Kourtnik, A,Egan, KM,Sahebjum, S,D'Agostino, D,Kumar, NB(2018).Targeting the Warburg effect for cancer treatment: ketogenic diets for management of glioma.Semin Canc Biol.
  73. Poff, AM,Ari, C,Seyfried, TN,D'Agostino, DP(2013).The ketogenic diet and hyperbaric oxygen therapy prolong survival in mice with systemic metastatic cancer.PLoS One,8(6),e65522.
  74. Pollak, M(2012).The insulin and insulin-like growth factor receptor family in neoplasia: an update.Nat Rev Canc,12(3),159-169.
  75. Priebe, A,Tan, L,Wahl, H(2011).Glucose deprivation activates AMPK and induces cell death through modulation of Akt in ovarian cancer cells.Gynecol Oncol,122(2),389-395.
  76. Rieger, J,Bähr, O,Maurer, GD(2014).ERGO: a pilot study of ketogenic diet in recurrent glioblastoma.Int J Oncol,44(6),1843-1852.
  77. Santos, JG,Da Cruz, WMaS,Schönthal, AH(2017).Patient with recurrent glio-blastoma responding favorably to ketogenic diet combined with intranasal delivery of perillyl alcohol: a case report and literature review.Arq Bras Neurocir Braz Neurosurg,36(3),194-199.
  78. Santos, JG,Da Cruz, WMS,Schonthal, AH(2018).Efficacy of a ketogenic diet with concomitant intranasal perillyl alcohol as a novel strategy for the therapy of recurrent glioblastoma.Oncol Lett,15(1),1263-1270.
  79. Schmidt, M,Pfetzer, N,Schwab, M,Strauss, I,Kämmerer, U.(2011).Effects of a ketogenic diet on the quality of life in 16 patients with advanced cancer: a pilot trial.Nutr Meta,8(1),54.
  80. Schroeder, U,Himpe, B,Pries, R,Vonthein, R,Nitsch, S,Wollenberg, B(2013).Decline of lactate in tumor tissue after ketogenic diet: in vivo microdialysis study in patients with head and neck cancer.Nutr Canc,65(6),843-849.
  81. Schulte G, Schütz H. Insulin in der Krebsbehandlung. Münchener Med Wochenschr. 1942;89(29):648-650
  82. Schwalb, M,Taubmann, M,Hines, S,Reinwald, H,Ruggiero, M(2016).Clinical observation of a novel, complementary, immunotherapeutic approach based on ketogenic diet, chondroitin sulfate, vitamin D 3, oleic acid and a fermented milk and colostrum product.Am J Immunol,12(4),91-98.
  83. Schwartz, K,Chang, HT,Nikolai, M(2015).Treatment of glioma patients with ketogenic diets: report of two cases treated with an IRB-approved energy-restricted ketogenic diet protocol and review of the literature.Canc Metabol,3,3.
  84. Schwartz, KA,Noel, M,Nikolai, M,Chang, HT(2018).Investigating the ketogenic diet as treatment for primary aggressive brain cancer: challenges and lessons learned.Front Nutr,5,11.
  85. Seyfried, TN(2015).Cancer as a mitochondrial metabolic disease.Front Cell Dev Biol,3,43.
  86. Seyfried, TN,Flores, RE,Poff, AM,D'Agostino, DP(2014).Cancer as a metabolic disease: implications for novel therapeutics.Carcinogenesis,35(3),515-527.
  87. Seyfried, TN,Shelton, LM(2010).Cancer as a metabolic disease.Nutr Metab,7,7.
  88. Seyfried, TN,Yu, G,Maroon, JC,D'Agostino, DP(2017).Press-pulse: a novel therapeutic strategy for the metabolic management of cancer.Nutr Metab,14,19.
  89. Shukla, SK,Gebregiworgis, T,Purohit, V(2014).Metabolic reprogramming induced by ketone bodies diminishes pancreatic cancer cachexia.Canc Metabol,2,18.
  90. Silberstein F, Freud J, Révész T. Versuehe, inoperable Carcinome mit Insulin zu behandeln. Z Gesamte Exp Med. 1927;55(1):78-102
  91. Skinner, R,Trujillo, A,Ma, X,Beierle, EA(2009).Ketone bodies inhibit the viability of human neuroblastoma cells.J Pediatr Surg,44(1),212-216.
  92. Spitz, DR,Sim, JE,Ridnour, LA,Galoforo, SS,Lee, YJ(2000).Glucose deprivation-induced oxidative stress in human tumor cells. A fundamental defect in metabolism?.Ann N Y Acad Sci,899,349-362.
  93. Strowd, RE,Cervenka, MC,Henry, BJ,Kossoff, EH,Hartman, AL,Blakeley, JO(2015).Glycemic modulation in neuro-oncology: experience and future directions using a modified Atkins diet for high-grade brain tumors.Neuro-Oncology Pract,2(3),127-136.
  94. Sullivan, LB,Chandel, NS(2014).Mitochondrial reactive oxygen species and cancer.Canc Metabol,2,17.
  95. Tannenbaum A. The dependence of tumor formation on the composition of the calorie-restricted diet as well as on the degree of restriction. Canc Res. 1945;5(11):616-625
  96. Tan-Shalaby, JL,Carrick, J,Edinger, K(2016).Modified Atkins diet in advanced malignancies - final results of a safety and feasibility trial within the Veterans Affairs Pittsburgh Healthcare System.Nutr Metab,13,52.
  97. Tisdale, MJ,Brennan, RA(1983).Loss of acetoacetate coenzyme A transferase activity in tumours of peripheral tissues.Br J Canc.,47(2),293-297.
  98. Toth, , C,Clemens, Z(2017).Treatment of rectal cancer with the paleolithic ketogenic diet: a 24-months follow-up.Am J Med Case Reports,5(8),205-216.
  99. Tóth, C,Clemens, Z(2016).Halted progression of soft palate cancer in a patient treated with the paleolithic ketogenic diet alone.Am J Med Case Reports,4(8),288-292.
  100. Tóth, C,Schimmer Zsófia Clemens, M(2018).Complete cessation of recurrent cervical intraepithelial neoplasia (CIN) by the paleolithic ketogenic diet: a case report.J Cancer Res Treat,6(1),1-5.
  101. Van Alstyne EVN, Beebe SP. Diet studies in transplantable tumors - I. The effect of non-carbohydrate DIet upon the growth of transplantable sarcoma in rats. J Media Res. 1913;29(2):217-232
  102. Verschoor, ML,Ungard, R,Harbottle, A,Jakupciak, JP,Parr, RL,Singh, G(2013).Mito-chondria and cancer: past, present, and future.BioMed Res Int,2013,612369.
  103. Warburg O, Posener K, Negelein E. Über den Stoffwechsel der Carcinomzelle. Biochem Z. 1924;152:309-343
  104. Warburg O, Wind F, Negelein E. The metabolism of tumors in the body. J Gen Physiol. 1927;8(6):519-530
  105. Warburg O, Wind F, Negelein E. Über den Stoffwechsel der Tumoren im Korper.Klin Wochenschr. 1926;5:829-838
  106. Weber, DD,Aminazdeh-Gohari, S,Kofler, B(2018).Ketogenic diet in cancer therapy.Aging,10(2),164-165.
  107. Weiss, J(1957).Über Erfahrungen mit Insulin und kohlenhydratreduzierender Diat bei inkurablen Krebskranken.Med Klin,52(27),1190-1191.
  108. Winter, SF,Loebel, F,Dietrich, J(2017).Role of ketogenic metabolic therapy in malignant glioma: a systematic review.Crit Rev Oncol Hematol,112,41-58.
  109. Yoshikawa, T,Noguchi, Y,Doi, C,Makino, T,Okamoto, T,Matsumoto, A(1999).Insulin resistance was connected with the alterations of substrate utilization in patients with cancer.Canc Lett,141(1-2),93-98.
  110. Yoshikawa, T,Noguchi, Y,Matsumoto, A(1994).Effects of tumor removal and body weight loss on insulin resistance in patients with cancer.Surgery,116(1),62-66.
  111. Zahra, A,Fath, MA,Opat, E(2017).Consuming a ketogenic diet while receiving radiation and chemotherapy for locally advanced lung cancer and pancreatic cancer: the University of Iowa experience of two phase 1 clinical trials.Radiat Res,187(6),743-754.
  112. Zuccoli, G,Marcello, N,Pisanello, A(2010).Metabolic management of glioblas-toma multiforme using standard therapy together with a restricted ketogenic diet: case report.Nutr Metab,7,33.
被引用次数
  1. Reinhart A. Sweeney,Rainer J. Klement,Gabriele Schäfer(2020).A ketogenic diet exerts beneficial effects on body composition of cancer patients during radiotherapy: An interim analysis of the KETOCOMP study.Journal of Traditional and Complementary Medicine,10(3),180-187.
print cancel